2021
DOI: 10.1016/j.injury.2021.01.043
|View full text |Cite
|
Sign up to set email alerts
|

Autologous bone graft: Is it still the gold standard?

Abstract: Bone grafting has over 100 years of successful clinical use. Despite the successes of autograft bone transplantation, complications of bone grafting are significant, mostly at the donor site. This article reviews the biology of fracture healing, the properties of bone grafts, and reviews the specific advantages and problems associated with autograft bone. Recent techniques such as the Reamer Irrigator Aspirator are described, which has dramatically reduced complications of bone autograft harvesting.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
153
0
4

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 268 publications
(209 citation statements)
references
References 24 publications
0
153
0
4
Order By: Relevance
“… 1–3 Standard treatment strategies for bone defects employ autologous bone grafting, which has limited availability and may cause additional complications. 4 , 5 Allografts, as another potential clinical option, are rarely used because of the potential risks such as disease transmission and immune rejection. 6 , 7 …”
Section: Introductionmentioning
confidence: 99%
“… 1–3 Standard treatment strategies for bone defects employ autologous bone grafting, which has limited availability and may cause additional complications. 4 , 5 Allografts, as another potential clinical option, are rarely used because of the potential risks such as disease transmission and immune rejection. 6 , 7 …”
Section: Introductionmentioning
confidence: 99%
“…Biodegradable scaffolds, including calcium phosphate, aerogels [ 1 , 2 , 3 , 4 , 5 , 6 ], autologous [ 7 , 8 , 9 ], allogeneic [ 10 , 11 , 12 ], or xenogeneic grafts [ 13 , 14 , 15 , 16 , 17 ] demonstrate significant efficiency as bone substitute materials. Ideally, biocompatible materials’ resorption rate coincides with the formation rate of the new organotypic tissue.…”
Section: Introductionmentioning
confidence: 99%
“…A major clinical challenge in orthopedic and craniomaxillofacial (CMF) surgery is the development of critically sized bone defects typically caused by congenital malformations, trauma, infection, cancer, or surgical resection [1,2]. Multiple treatment approaches have been implemented to address such defects such as the use of allographs [3], however, the gold standard continues to be the use of autografts [4].…”
Section: Introductionmentioning
confidence: 99%